Mailed Outreach Doubles Hepatocellular Carcinoma (HCC) Surveillance Imaging Uptake
Inside Precision Medicine
From Inside Precision Medicine:
Researchers from the Perelman School of Medicine at the University of Pennsylvania have shown that uptake of surveillance imaging for hepatocellular carcinoma (HCC) can be doubled by sending at-risk patients a letter with a pre-signed ultrasound order.
“Our findings show that an approach like this can meaningfully increase liver cancer surveillance, which is particularly important in a group of patients who are high risk for liver cancer,” said Shivan Mehta, MD, MBA, an associate professor of Gastroenterology and the associate chief innovation officer at Penn Medicine.